11. O-001 A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohn's Disease Refractory to Anti-TFNα: UNITI-1. (March 2016) Authors: Sandborn, William; Gasink, Christopher; Blank, Marion; Lang, Yinghua; Johanns, Jewel; Gao, Long-Long; Sands, Bruce; Hanauer, Stephen; Feagan, Brian; Targan, Stephan; Ghosh, Subrata; de Villiers, Wim; Colombel, Jean-Frédéric; Lee, Scott; Desreumaux, Pierre; Loftus, Edward; Vermeire, Severine; Rutg... Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. O-001 A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohn's Disease Refractory to Anti-TFNα: UNITI-1. (March 2016) Authors: Sandborn, William; Gasink, Christopher; Blank, Marion; Lang, Yinghua; Johanns, Jewel; Gao, Long-Long; Sands, Bruce; Hanauer, Stephen; Feagan, Brian; Targan, Stephan; Ghosh, Subrata; de Villiers, Wim; Colombel, Jean-Frédéric; Lee, Scott; Desreumaux, Pierre; Loftus, Edward; Vermeire, Severine; Rutg... Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. O30 Closure of perianal fistula in patients receiving ustekinumab in the SEAVUE and STARDUST trials. (19th June 2022) Authors: Laurent, Peyrin-Biroulet; Panaccione, Remo; Gasink, Christopher; Hoops, Timothy; Izanec, James L; Ma, Tony; Nazar, Maciej; Bravata, Ivana; Lahaye, Marjolein; Irving, Peter M; Loftus, Edward; Danese, Silvio; Sands, Bruce Journal: Gut Issue: Volume 71(2022)Supplement 1 Page Start: A17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. P-016 YI Mucosal Healing Is Associated with Improved Long-Term Outcomes in Crohn's Disease: A Systematic Review and Meta-analysis. (March 2016) Authors: Shah, Shailja; Colombel, Jean-Frédéric; Sands, Bruce; Narula, Neeraj Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. P-016 YI Mucosal Healing Is Associated with Improved Long-Term Outcomes in Crohn's Disease: A Systematic Review and Meta-analysis. (March 2016) Authors: Shah, Shailja; Colombel, Jean-Frédéric; Sands, Bruce; Narula, Neeraj Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. P-017 YI Mucosal Healing Is Associated with Improved Long-Term Outcomes in Ulcerative Colitis: A Systematic Review and Meta-analysis. (1st March 2016) Authors: Shah, Shailja; Colombel, Jean-Frédéric; Sands, Bruce; Narula, Neeraj Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. P-017 YI Mucosal Healing Is Associated with Improved Long-Term Outcomes in Ulcerative Colitis: A Systematic Review and Meta-analysis. (March 2016) Authors: Shah, Shailja; Colombel, Jean-Frédéric; Sands, Bruce; Narula, Neeraj Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. P-017 YI Mucosal Healing Is Associated with Improved Long-Term Outcomes in Ulcerative Colitis: A Systematic Review and Meta-analysis. (March 2016) Authors: Shah, Shailja; Colombel, Jean-Frédéric; Sands, Bruce; Narula, Neeraj Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. P-040 Assessing Risk Factors Predicting Loss of Response to Vedolizumab in Ulcerative Colitis and Crohn's Disease: Outcomes from the VICTORY Consortium. (February 2017) Authors: Shmidt, Eugenia; Winters, Adam; Katta, Leah; Chaudrey, Khadija; Kochhar, Gursimran; Parikh, Malav; Luo, Michelle; Barocas, Morris; Boland, Brigid; Singh, Siddharth; Hudesman, David; Lukin, Dana; Sandborn, William; Shen, Bo; Siegel, Corey; Loftus, Edward; Kane, Sunanda; Sands, Bruce; Colombel, Jea... Journal: Inflammatory bowel diseases Issue: Volume 23(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. P-049 Validated Prediction Model for Clinical Remission with Vedolizumab in Crohn's Disease: Post Hoc Analysis of GEMINI II Clinical Trial. (February 2017) Authors: Dulai, Parambir; Boland, Brigid; Singh, Siddharth; Siegel, Corey; Loftus, Edward; Kane, Sunanda; Sands, Bruce; Colombel, Jean-Frédéric; Sandborn, William; Lasch, Karen; Previtali, Alessandro Journal: Inflammatory bowel diseases Issue: Volume 23(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗